PPD Discovery, a wholly-owned subsidiary of PPD, Inc. has established a relationship with New England Biolabs, Inc. (NEB) to produce and sell recombinant human cytochrome P450 (CYP450) enzymes expressed in bacteria using PPD Discovery’s proprietary Pharmazyme technology. Under the terms of the agreement, NEB receives a non-exclusive license to make and sell human CYP450 enzymes Read more about PPD Discovery Licenses Its Pharmazyme Technology[…]